James Flynn serves as the Managing Partner and CEO of Deerfield Capital Management. See sector focus and contact routes.
James Flynn serves as the Managing Partner and CEO of Deerfield Capital Management, a New York-based venture capital firm, where he leverages prior experience as a growth equity investor at General Atlantic and a Partner at Sequoia Capital focusing on post-Series A technology investments. His investment thesis targets emerging technology sectors including artificial intelligence, generative media, and brain-computer interfaces, with a geographic focus on backing prominent companies in the United States. Flynn typically participates in growth-stage funding rounds, such as the 2025 rounds for Neuralink and fal, and the 2026 round for Anthropic, often acting as a participant in these later-stage deals. Notable portfolio companies under his management include Anthropic, Neuralink, ElevenLabs, and Clay, which represent key players in AI and biotechnology. While specific check sizes and lead/follow distinctions are not explicitly detailed in available records, his activity confirms a focus on growth capital rather than early seed funding. Flynn has also expressed a distinctive point of view on biotechnology, noting that Deerfield invests across the entire healthcare value
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in New York.
Investors like James Flynn · Full investor directory · Investor access · Company funding database